Chapter 25. Medical Management of Stable Coronary Artery Disease

  1. Salim Yusuf DPhil, FRCPC, FRSC Research Chair Professor of Medicine Director Vice President Research4,5,6,
  2. John A Cairns MD, FRCPC Professor of Medicine Former Dean7,
  3. A John Camm MD British Heart Foundation Professor Head of Cardiac8,
  4. Ernest L Fallen MD, FRCPC Professor Emeritus9 and
  5. Bernard J Gersh MB, ChB, DPhil Consultant Professor of Medicine10
  1. William E Boden MD, FACC Professor Clinical Chief Chief of Cardiology1,2,3

Published Online: 21 MAY 2010

DOI: 10.1002/9781444309768.ch25

Evidence-Based Cardiology, Third Edition

Evidence-Based Cardiology, Third Edition

How to Cite

Boden, W. E. (2009) Medical Management of Stable Coronary Artery Disease, in Evidence-Based Cardiology, Third Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444309768.ch25

Editor Information

  1. 4

    McMaster University, Canada

  2. 5

    Population Health Research Institute, McMaster University, Hamilton Health Sciences, Canada

  3. 6

    Hamilton Health Sciences, Hamilton, Ontario, Canada

  4. 7

    Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  5. 8

    St George's University of London, London, UK

  6. 9

    McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

  7. 10

    Mayo Clinic College of Medicine, Rochester, MN, USA

Author Information

  1. 1

    Medicine and Preventive Medicine, University at Buffalo, School of Medicine and Public Health, Buffalo, NY, USA

  2. 2

    Division of Cardiovascular Medicine, University of New York at Buffalo, Buffalo, NY, USA

  3. 3

    Buffalo General and Millard Fillmore Hospitals, Buffalo, NY, USA

Publication History

  1. Published Online: 21 MAY 2010
  2. Published Print: 13 NOV 2009

ISBN Information

Print ISBN: 9781405159258

Online ISBN: 9781444309768



  • stable coronary artery disease - medical management;
  • stable angina - chest, neck, arms, and jaws discomfort;
  • increased revascularization - increasing residual ischemia;
  • chronic stable angina pectoris - substernal/precordial chest discomfort;
  • antianginal agents - myocardial ischemia;
  • multifactorial risk reduction - coronary luminal narrowing rate;
  • antiplatelet agents preventing CVD - aspirin, clopidogrel;
  • acute coronary syndrome - dual antiplatelet therapy


This chapter contains sections titled:

  • Introduction

  • Epidemiology

  • Definition and classification

  • Pathophysiology

  • Medical management of myocardial schemia

  • Role of myocardial revascularization

  • Recommended initial management approach in stable coronary artery disease patients with angina

  • Conclusion

  • References